ME/CFS patients also exhibited increased complement activation (especially C1q, C3, and C4 levels), which may even be used for clustering disease severity in this patient population itself [29], highlighting, once more, the similarities between PCS and ME/CFS conditions. The gene discussed is C3; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.